Ticker Scorecard - LQDA Basics Company: Liquidia Technologies, Inc. IPO Date: July 23, 2018 Sector: Healthcare Industry: Biotech Market Cap: $1.36B Activated in VL: True Average Daily Range Avg Daily Range: $0.29 | 3.44% Avg Daily Range (30 D): $0.28 | 2.01% Avg Daily Range (90 D): $0.22 | 1.79% Institutional Daily Volume Avg Daily Volume: .55M Avg Daily Volume (30 D): .75M Avg Daily Volume (90 D): .67M Trade Size Avg Trade Size (Sh.): 119 Avg Trade Size (Sh.) (30 D): 73 Avg Trade Size (Sh.) (90 D): 70 Institutional Trades Total Inst.Trades: 488 Avg Inst. Trade: $1.42M Avg Inst. Trade (30 D): $1.12M Avg Inst. Trade (90 D): $1.29M Avg Inst. Trade Volume: .14M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.52M Avg Closing Trade (30 D): $.99M Avg Closing Trade (90 D): $1.19M Avg Closing Volume: 152.85K     News Jan 14, 2025 @ 6:00 PM Evolving Landscape of Cardiology Segment: Key Mark... Source: Delveinsight Oct 7, 2024 @ 2:00 PM United States Supreme Court Declines to Review Rul... Source: N/A Oct 2, 2024 @ 10:00 AM Liquidia and Pharmosa Biopharm Expand Collaboratio... Source: N/A Aug 19, 2024 @ 10:00 AM U.S. FDA Grants Tentative Approval of YUTREPIAââ€... Source: Liquidia Corporation Jul 16, 2024 @ 1:39 AM Liquidia corp chief medical officer sells $18.4k i... Source: Investing.Com Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.62 $-.3 $-.37 Diluted EPS $-1.62 $-.3 $-.37 Revenue $ 15.61M $ 4.45M $ 3.66M Gross Profit $ 10.09M $ 2.88M $ 2.17M Net Income / Loss $ -119.48M $ -23.16M $ -27.94M Operating Income / Loss $ -111.62M $ -29.19M $ -27.2M Cost of Revenue $ 5.52M $ 1.57M $ 1.49M Net Cash Flow $ 128.14M $ 71.28M $ -24.77M PE Ratio